Dennis Michael White

Array ( [id] => 6080120 [patent_doc_number] => 20110142845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/880333 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17266 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142845.pdf [firstpage_image] =>[orig_patent_app_number] => 12880333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070107 [patent_doc_number] => 20110044957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHODS AND SYSTEMS FOR EXTENDED IN VITRO CULTURE OF NEURONAL CELLS' [patent_app_type] => utility [patent_app_number] => 12/861754 [patent_app_country] => US [patent_app_date] => 2010-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8803 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044957.pdf [firstpage_image] =>[orig_patent_app_number] => 12861754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831886 [patent_doc_number] => 08940700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'E-selectin compositions and use thereof for inducing E-selectin tolerance' [patent_app_type] => utility [patent_app_number] => 12/859048 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 52 [patent_no_of_words] => 21562 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601637 [patent_doc_number] => 20100322947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING AVELLINO CORNEA DYSTROPHY COMPRISING AN ANTIBODY AGAINST TGF-BETA' [patent_app_type] => utility [patent_app_number] => 12/858241 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2932 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322947.pdf [firstpage_image] =>[orig_patent_app_number] => 12858241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095269 [patent_doc_number] => 20110002914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'HYBRID TETNUS TOXOID PROTEINS THAT MIGRATE RETROGRADELY AND TRANSYNAPTICALLY INTO THE CNS' [patent_app_type] => utility [patent_app_number] => 12/831976 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8507 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002914.pdf [firstpage_image] =>[orig_patent_app_number] => 12831976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312589 [patent_doc_number] => 20120189613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'STIM2-MEDIATED CAPACITIVE CALCIUM ENTRY' [patent_app_type] => utility [patent_app_number] => 13/375202 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20116 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234670 [patent_doc_number] => 20100266492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'COMPOUNDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOIETIES TO NERVE CELLS' [patent_app_type] => utility [patent_app_number] => 12/749339 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6080 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266492.pdf [firstpage_image] =>[orig_patent_app_number] => 12749339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229897 [patent_doc_number] => 20100184105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ASSESSING NEURONAL DAMAGE FROM BLOOD SAMPLES' [patent_app_type] => utility [patent_app_number] => 12/726064 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6570 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184105.pdf [firstpage_image] =>[orig_patent_app_number] => 12726064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171304 [patent_doc_number] => 20120107321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Antibodies And Epitopes Specific To Misfolded Prion Protein' [patent_app_type] => utility [patent_app_number] => 13/254047 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13677 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107321.pdf [firstpage_image] =>[orig_patent_app_number] => 13254047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725319 [patent_doc_number] => 08404434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Method for determining degree of negative effect of macrophages on vertebrate' [patent_app_type] => utility [patent_app_number] => 12/656809 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2911 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12656809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535015 [patent_doc_number] => 08048639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Method for evaluating risk in multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 12/704257 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9376 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048639.pdf [firstpage_image] =>[orig_patent_app_number] => 12704257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882631 [patent_doc_number] => 08969397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Systems and methods to treat pain locally' [patent_app_type] => utility [patent_app_number] => 12/701261 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8141 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12701261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270741 [patent_doc_number] => 20100254986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'METHOD FOR MAKING HETEROMULTIMERIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/700618 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21870 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254986.pdf [firstpage_image] =>[orig_patent_app_number] => 12700618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500406 [patent_doc_number] => 20110262935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'METHOD FOR DETECTING A PRION INFECTION' [patent_app_type] => utility [patent_app_number] => 13/141483 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5365 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262935.pdf [firstpage_image] =>[orig_patent_app_number] => 13141483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445559 [patent_doc_number] => 20100279893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'In vitro model of spinal muscular atrophy' [patent_app_type] => utility [patent_app_number] => 12/653932 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 9428 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279893.pdf [firstpage_image] =>[orig_patent_app_number] => 12653932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247147 [patent_doc_number] => 20100136573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'DIAGNOSING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/627851 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 15797 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136573.pdf [firstpage_image] =>[orig_patent_app_number] => 12627851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580255 [patent_doc_number] => 20110294138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'METHODS FOR SIMULTANEOUSLY MEASURING THE IN VIVO METABOLISM OF TWO OR MORE ISOFORMS OF A BIOMOLECULE' [patent_app_type] => utility [patent_app_number] => 13/129036 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9451 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294138.pdf [firstpage_image] =>[orig_patent_app_number] => 13129036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8293966 [patent_doc_number] => 08221748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Compositions and methods for the systemic treatment of arthritis' [patent_app_type] => utility [patent_app_number] => 12/578332 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 6485 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383810 [patent_doc_number] => 20100317109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'FACTOR' [patent_app_type] => utility [patent_app_number] => 12/570659 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21324 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317109.pdf [firstpage_image] =>[orig_patent_app_number] => 12570659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046613 [patent_doc_number] => 08541166 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-09-24 [patent_title] => 'Peptide sequences for binding infectious prions' [patent_app_type] => utility [patent_app_number] => 12/571275 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2283 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12571275 [rel_patent_id] =>[rel_patent_doc_number] =>)